---
schema_version: "secwatch.filing_event.v1"
accession: "0000875320-25-000194"
form_type: "8-K"
ticker: "VRTX"
cik: "0000875320"
company_name: "VERTEX PHARMACEUTICALS INC / MA"
filed_at: "2025-05-14T23:59:59+00:00"
generated_at: "2026-05-21T11:52:46.193744+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Vertex shareholders elect all 11 directors, reject golden parachute proposal at 2025 annual meeting

## Summary
- All 11 director nominees elected with majority support; Bruce Sachs received lowest 'for' votes at 211.6M.
- Ratification of Ernst & Young as auditor for FY2025 passed with 229.4M votes for, 6.9M against.
- Advisory vote on 2024 named executive officer compensation approved: 208.9M for, 17.0M against.
- Shareholder proposal on excessive golden parachutes rejected: 84.1M for, 141.6M against.

## SEC filing metadata
- accession: 0000875320-25-000194
- form_type: 8-K
- ticker: VRTX
- cik: 0000875320
- company_name: VERTEX PHARMACEUTICALS INC / MA
- filed_at: 2025-05-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/875320/000087532025000194/0000875320-25-000194-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/875320/000087532025000194/vrtx-20250514.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000875320-25-000194
- JSON: https://secwatch.observer/filing/0000875320-25-000194.json
- Plain text: https://secwatch.observer/filing/0000875320-25-000194.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.